ScholarWorks@Hanyang University: Kim, Seung Hyun

Detailed Information

Kim, Seung Hyun (김승현)

COLLEGE OF MEDICINE (DEPARTMENT OF NEUROLOGY)

Research Area

Tel 02-2290-8371
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Amyotrophic lateral sclerosis:39||amyotrophic lateral sclerosis:20||s disease:15||Alzheimer&apos:11||ALS:11||Dementia:7||Amyotrophic lateral sclerosis (ALS):7||prognosis:6||stroke:6||Frontotemporal dementia:6||Ischemic stroke:5||Korean:5||Microglia:5||neuronal cell death:5||neurotoxicity:4||neuroprotection:4||PARP1 inhibitor:4||frontotemporal dementia:4||Amyotrophic Lateral Sclerosis (ALS):4||SOD1:4||Glycogen synthase kinase3:4||Mesenchymal stem cells:4||glycogen synthase kinase3:4||Neuroinflammation:4||oxidative stress:4||erythropoietin:3||Mesenchymal stromal cells:3||GSK3 beta inhibitor:3||GSK3 inhibitor:3||Epidemiology:3||Neuroprotection:3||Motor neuron disease:3||Depression:3||FUS:3||Posterior tibial nerve:3||Mutation:3||quality of life:3||Prognostic factors:3||Validity:3||Care:3||Policy:3||LDOPA:3||C9orf72:2||Key Words: Progressive multifocal leukoencephalopathy:2||Gerotarget:2||Natural history:2||Korea:2||School record:2||Neural stem cells:2||Korean version:2||Neurodegenerative disease:2||Neurodegenerative diseases:2||s encephalopathy:2||cytokines:2||ALS Functional Rating ScaleRevised (ALSFRSR):2||Gradient echo MRI:2||Lacunar stroke:2||Extrinsic apoptosis:2||Neurophysiological Index (NI):2||Guideline:2||Autopsy:2||Clinical characteristics:2||Herpes simplex encephalitis:2||Longterm culture:2||tau:2||donepezil:2||MAPT:2||transgenic mouse:2||MMP9:2||Nextgeneration sequencing:2||Biomarkers:2||Clinical trials:2||Diffusion weighted image:2||Optic neuritis:2||Hypoxia:2||Magnetic resonance spectroscopy:2||frontotemporal lobar degeneration:2||Parkinson&apos:2||Median nerve:2||Caregiver burden:2||Caregiver burden:2||Mesenchymal stem cells (MSCs):2||Amyotrophic Lateral Sclerosis:2||Pediatric epilepsy:2||Tractography:2||Bone marrow:2||Microbleeds:2||Phosphatidylinositol 3kinase:2||induced neuron:2||inflammation:2||inhibitor:2||Crohn&apos:2||lacunar infarction:2||Valproic acid (VPA):2||liquidliquid phase separation:2||Poly(ADPribose)polymerase:2||Migration:2||magnetic resonance imaging:2||Wernicke&apos:2||Precision medicine:2||White matter changes:2||mesenchymal stem cell:2||mesenchymal stem cells:2||Bone marrow mesenchymal stromal cells (BMMSCs):2||GRN:2||Inflammation:2||amyloid beta:2||mutation:2||amyloidbeta:2||Amyotrophic Lateral Sclerosis functional rating scalerevised (ALSFRSR):2||neurodegenerative disease:2||Intracranial arterial stenosis:2||Braincomputer interface (BCI):2||Cerebral palsy:2||Registries:2||Relapse:2||Reliability:2||biomarkers:2||bloodbrain barrier:2||JGK263:2||Retinal microvascular abnormalities:2||Cerebrovascular disorder:2||Erythropoietin:2||posttranslational modification:2||precision medicine:2||Gef26:1||Gender:1||Gene:1||Gene delivery:1||Gene expression:1||GeneGo analysis:1||Geriatric nutritional risk index:1||Gout:1||Granulocyte colonystimulating factor:1||HIRA:1||Health:1||Health services needs and demand:1||Hexanucleotide repeat:1||Histone deacetylase (HDAC):1||Homeostasis:1||Human bone marrow mesenchymal stem cells (hMSCs):1||Human cell models:1||Humancomputer interface (HCI):1||Hypoxia/reoxygenation preconditioning:1||IL10:1||IL4:1||IPA:1||Idiopathic facial nerve paralysis:1||Immune modulation:1||In vivo study:1||Incidence:1||Induced neuron:1||Infliximab:1||Injection:1||Integrated:1||Intraoperative Neurophysiologic Monitoring:1||Intrathecal:1||Intrathecal injection:1||Investigatorinitiated trial:1||Iron:1||Ischemic stroke model:1||JMJD3:1||JPI289:1||Jmjd2b:1||K40I:1||Knowledge:1||Korean family:1||Lxylulose reductase (DCXR):1||LMNA gene:1||Lenzumestrocel:1||Leu162Pro:1||Lipid bilayer:1||Lipopolysaccharide:1||Lipopolysaccharides:1||Lockedin syndrome (LIS):1||M139I:1||MIBG scintigraphy:1||MRI:1||MUNE:1||MUNIX:1||Macronutrients:1||Magnetic:1||Mass screening:1||Meat Prognosis:1||Mediating effects:1||Meningoencephalitis:1||Mesenchymal stromal cell:1||MetaCore pathway analysis software (GeneGo):1||Microtubules:1||Missense mutation:1||Mitochondria:1||Mobility:1||Mobilized peripheral blood mononuclear cells:1||Monovalent cation:1||Motor behavioral dysfunction:1||Motor cortex:1||Motor neuron:1||Motor neuronal loss:1||Multigene panel:1||Multiple Sclerosis:1||Mutations:1||Myasthenia gravis:1||NCKAP1:1||NE4C cells:1||NEUROIMMUNOLOGY:1||NF?B:1||NGS:1||Nanovectors:1||National health insurance service:1||National responsibility policy:1||Needs:1||Needs assessment:1||Neurodegeneration:1||Neurodegenerative Diseases:1||Neurogenin 1 (Ngn1):1||Neuromyelitis Optica:1||Neuron:1||Neuronal cytoplasmic inclusion:1||Neuronal differentiation:1||Neurophysiological index:1||Neuropsychiatric Inventory:1||Neuropsychiatric Inventory Questionnaire:1||Neuropsychiatric symptoms:1||Neuropsychological inventory:1||Neuroregeneration:1||Neurotoxicity:1||Neurotrophic effect:1||Neurotrophic factor:1||Neurotrophic factors:1||Nitrous oxide:1||Novel mutation:1||Nuclear localization signal:1||Oxidative stress:1||PARP:1||PARP1:1||PP2A:1||PRNP:1||Parkinsonism:1||Passagedependency:1||Pathogenic:1||Pathophysiology:1||Pattern classification:1||Peripheral blood stem cell:1||Personalized Medicine:1||Phagocytosis:1||Phase III:1||Phenanthridines:1||Poly(ADPribose) polymerase:1||Poly(ADPribose)polymerase PARP1:1||Precision pharmacology:1||Presenilin 1:1||Prevalence:1||Primary progressive aphasia:1||Protection:1||Psychological adaptation:1||Public Education:1||Pulmonary embolism:1||Quality of life:1||Quantitative susceptibility mapping:1||RAPGEF2:1||RG108:1||RUNX2:1||Radioimmunoprecipitation assay:1||Radionuclide image:1||Regulatory T cell:1||Research:1||Revised ALS functional rating scale:1||Riemannian geometry:1||SHSY5Y cells:1||SIGMAR1:1||SIRT1:1||SOD1(G93A) transgenic mice:1||Saccade:1||Safety:1||Salivary glands:1||Senescence:1||Seronegative myasthenia gravis:1||Sex:1||Sexual dimorphism:1||Sialorrhea:1||Sjogren&apos:1||Social adjustment:1||Solvent shifting:1||Spinocerebellar ataxia type 2:1||Sporadic:1||Staging system:1||Steadystate visual evoked potential (SSVEP):1||Stem Cells:1||Stem cell:1||Stem cell therapy:1||Stem cells:1||Steroid:1||Streptococcus pneumoniae:1||Stress granules:1||Stress hormone:1||Stress vulnerability:1||Stroke:1||Stroke outcome:1||Stromal cellderived factor1 alpha:1||Subacute combined degeneration:1||Superior mesenteric artery syndrome:1||Superoxide dismutase1 (SOD1):1||Survival:1||Synaptic growth:1||Systems biology:1||TAU:1||TBK1:1||TGFbeta:1||TGFbeta2:1||THP1 cells:1||TNFalpha antagonist:1||Tacrolimus:1||Tau hyperphosphorylation:1||Tetrodotoxinsensitive Na+ current:1||The recipients of public care system:1||Thiopyranoquinoline derivatives:1||Thymectomy:1||Total daily energy expenditure:1||Transgenic mouse:1||Tricyclic derivatives:1||Trophic factors:1||UBQLN2:1||Upper motor neuron signs:1||Uric acid:1||Variant:1||Vitamin D:1||Voxel Based Morphometry:1||White matter:1||Whole exome sequencing:1||acid sphingomyelinase:1||adult stem cells:1||aging:1||amyloid toxicity:1||angiotensin II:1||antioxidative effect:1||apoptosis:1||aquaporin 4:1||artificial intelligence:1||arytenoidectomy:1||atrophy:1||autoimmunity:1||autosomal dominant:1||bamboo salt soy sauce:1||behavior:1||betaPIX:1||betagalactosylceramidase:1||big data:1||biomarkerguided therapies:1||bone marrow mesenchymal stromal cells:1||brain MRI:1||bullous pemphigoid:1||cAMP:1||calcium channel:1||calcium channel blocker:1||captopril:1||caveolae:1||cell death mechanism:1||cell protection:1||cell therapy:1||cerebral ischaemia:1||charcotmarietooth disease:1||cholesterol:1||cilnidipine:1||cognition:1||cognitive impairment:1||communitybased cognitive intervention program:1||compound muscle action potential:1||cost of illness:1||cytosolic free Ca2+ concentration:1||dementia:1||depression:1||dhs21:1||diabetes:1||diagnosis:1||dietary fiber:1||dietary total antioxidant capacity:1||dilysine motif:1||direct conversion:1||disease progression rate:1||distal hereditary motor neuropathy 7B:1||distal myopathy with rimmed vacuoles:1||duplication:1||dynactin 1:1||dyslipidemia:1||economic burden:1||egg retention:1||elderly:1||emotion:1||emotion perception:1||epidemiology:1||eventfree survival:1||facial expression:1||familial ALS:1||frequency:1||fused in sarcoma:1||gender differences:1||gene networking:1||globoid cell leukodystrophy:1||glutathione transferase omega:1||glutathionylation:1||glycogen synthase kinase3 beta:1||gut microbiota:1||hemiparesis:1||hydrogen peroxide:1||hydroxycholesterol:1||immunoglobulin:1||immunomodulation:1||incidence:1||indoleamine 2:1||infarction:1||ischemia:1||krabbe disease:1||lenzumestrocel:1||lithium:1||liver X receptor:1||lowcomplexity domain:1||matrix metalloproteinase 9:1||matrix metalloproteinase9:1||memory improvement:1||microbleed:1||motor neuron disease:1||motor unit number:1||multiple sclerosis:1||muscarinic ligand:1||music therapy:1||nAChRs:1||nerve conduction velocity:1||neural function:1||neurogenerative disease:1||neurogenetics:1||neurological worsening:1||neuromyelitis optica:1||neuronal differentiation:1||neuroprotective effect:1||neuropsychology:1||nextgeneration sequencing:1||nicotinic acetylcholine receptors:1||ocular flutter:1||ocular myasthenia gravis:1||olivopontocerebellar atrophy:1||optokinetic stimulation:1||osmoregulation:1||palliative care:1||patientspecific cell model:1||permeability:1||phosphatidylinositol 3kinase:1||phosphatidylinositol3kinase:1||phosphoinositide 3 kinase:1||pilot study:1||prevalence:1||protein aggregation:1||proteostasis:1||protofibrils:1||psychometrics:1||psychosine:1||regulatory T cell:1||regulatory T lymphocyte:1||reliability and validity:1||repetitive nerve stimulation test:1||reproducibility:1||resveratrol:1||ribostasis:1||s dementia:1||s palsy:1||s syndrome:1||sensory nerve action potential:1||sigma(1) receptor:1||small compound:1||staging system:1||stem cell therapy:1||stress granule:1||superoxide dismutase:1||superoxide dismutase 1 (SOD 1):1||survival:1||survival analysis:1||systems biology:1||systems neurophysiology:1||systems pharmacology:1||tetrodotoxinsensitive Na+ current:1||thymoma:1||translation:1||translational research programs.:1||treatment:1||umbilical cord:1||umbilical cord vein:1||uric acid:1||vascular Parkinsonism:1||vascular endothelial growth factor:1||vasogenic brain edema:1||vegetable fiber:1||vocal cord:1||voltagegated K+ currents:1||voxelbased morphometry:1||wholeexome sequencing:1||xylitol:1||간병 부담감:1||근위축성측삭경화증:1||노인:1||뇌졸중:1||돌봄 제공자:1||삶의 질:1||우울:1||음악치료:1||.:1||편마비:1||25hydroxycholesterol:1||3dioxygenase:1||8Amino[1,2,4]triazolo[4,3a]pyridin3(2H)one derivatives:1||A beta plaques:1||A4F:1||AARS2:1||AChR antibody:1||AMPK:1||ANG variant:1||ANXA11:1||APMI:1||ASM direct inhibitor:1||ATXN2:1||Acid sphingomyelinase:1||Actual energy intake:1||Adult stem cells:1||Age at symptom onset:1||Aggregation:1||Akt:1||All of Us Research Program:1||Alzheimer’s Disease:1||Alzheimer’s disease:1||Amyloidbeta:1||Anatomical substrate:1||AntiMuSK antibody:1||Antiproliferation:1||Antioxidants:1||Apheresis:1||Apoptosis:1||Asia:1||Atherosclerosis:1||Autologous bone marrowderived mesenchymal stem cell:1||BMMSCs:1||BMP:1||Bacterial meningitis:1||Behavioral and psychological symptoms:1||Behavioral psychiatric symptoms of dementia:1||Bell&apos:1||Betacarotene:1||Biological marker:1||Biomarker:1||Biomarkerguided categorization:1||Body mass index:1||Bone density:1||Bone marrow transplantation (BMT):1||Bone marrowderived mesenchymal stem cell:1||Bone marrowmesenchymal stem cells (BMMSCs):1||Ctype lectin:1||CADASIL:1||CAG repeat expansion:1||CMT1A:1||CSF1R:1||CXCR4:1||Caregivers:1||Casecontrol study:1||Caspase3:1||Ce2+/Zn2+ superoxide dismutase:1||Cell Transplantation:1||Cell cycle:1||Cell membrane:1||Cellbased assay:1||Cervical thymoma:1||Cilostazol:1||Clinical assessment:1||Clinical feasibility:1||Clinical trial:1||Clodronate liposome:1||Clustering:1||Codon4:1||Coenzyme Q10:1||Cognitive impairment:1||Completely lockedin state (CLIS):1||Cytochrome c:1||Cytokine:1||DMRV:1||DNA methylation:1||DNA methyltransferases (DNMTs):1||DNMT inhibition:1||De novo mutation:1||Dementia screening test:1||Dementia support center:1||Demography:1||Dependency burden:1||Dicarbonyl:1||Diet:1||Dietary intake:1||Differentiation:1||Disease duration Korean:1||Disease incidence:1||Drosophila:1||Dysphagia:1||EAE:1||EEG:1||EGCG:1||ELISA:1||ER retention:1||ERK:1||Earlyonset Alzheimer&apos:1||Efficacy:1||Electroencephalography (EEG):1||Electrooculogram (EOG):1||EmeryDreifuss muscular dystrophy:1||Endocytic regulation of BMP signaling:1||Evoked Potential:1||Experimental Autoimmune Encephalomyelitis:1||Eyewriting:1||F20C:1||FK506:1||Facial nerve:1||Familial:1||Familial ALS:1||Family caregivers:1||Fluorescence recovery after photobleaching:1||Fruit:1||Functional ion channels:1||Fused in sarcoma:1||GCSF:1||G93A mutant SOD1 transgenic (SOD1) mice:1||GHSR1 alpha agonist:1||GNE gene:1||GSK3:1||GSK3 beta inhibition:1||GSK3:1||Gastrojejunostomy:1||

STATISTICS: Total View :4,853,154; Today View :4,377

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE